RN Mobile Menu

Search form




In this article, we highlight some of the most important pharma reports presented at ACR 2016 this year.

Gout patients who successfully respond to urate lowering therapy have higher rates of chronic kidney disease improvement, a study shows.

Gout and rheumatoid arthritis are both associated with premature mortality, researchers report.

New evidence-based clinical practice guidelines offer some strong—and not so strong—recommendations for effective gout diagnosis and treatment.


Researchers rank febuxostat as the most effective urate-lowering drug for reaching serum uric acid targets for gout patients.


How do rheumatologists and primary care physicians differ in treating patients with gout? This survey highlights some notable differences.


Gout’s relationship with food intake can be tricky, so which is better: Eating foods lower on the glycemic index scale or lower in carbohydrates?


Subscribe to Gout on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.